Publication | Open Access
Fulranumab for treatment of diabetic peripheral neuropathic pain
46
Citations
16
References
2014
Year
This study provides Class I evidence that in patients with DPNP, fulranumab 10 mg reduces pain by 1.2 points on an 11-point scale compared with placebo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1